Blood Vial

Dillon Steyl · 2026 · $4.99 · Action · deal grade B

Measured on 2026-10-01 21:25 UTC, 4 days ago. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

• Estimated net residual revenue: $782 to $1.2k per month
• Opportunity: $1.3k per month at x1.30 dormancy
• Estimated lifetime owners: 13.7k
• 96% positive across 367 reviews · 23.4 reviews/month

Why it's flagged

• Developer active, last post 1 months ago
• Studio active elsewhere (2 titles tracked), so this one may welcome a partner
• Store page localized in only 1 language(s)

Analyst notes (AI-assisted)

Note written 2026-09-01; the live figures above take precedence over any numbers in it.

A short, skill-based movement shooter where you swim through blood as your primary mechanic, blending Splatoon gunplay with roguelike structure.

Blood Vial is a fresh, mechanically sound title with exceptional review sentiment (96%) and solid residual revenue that punches above its profile. The core concept, blood as both aesthetic and gameplay substrate, is genuinely differentiated, and players are unified in wanting *more* of exactly what works. For a publisher or studio seeking a proven prototype to expand, or a small team looking to license IP mechanics, this represents a low-risk foundation with clear content roadmap signals already embedded in the community. Most realistic play: publishing.

• Risk: Median session is 1.8 hours and runs complete in 20–30 minutes, creating natural churn; expanding content density or progression loops will be critical to retention.
• Risk: Built by solo developer with only 0.3 months of post-launch support; scaling production and ongoing balance will require team augmentation.
• Risk: 11.7% localization gap (Brazilian Portuguese notably underserved) and single-language asset base may limit regional revenue uptake without translation investment.

This case as Markdown · Estimates carry ±30-50% error per title.